The arrival of Retatrutide ZPHC, at a strength of 120mg, is creating considerable buzz within the healthcare community. This groundbreaking dual GIP and GLP-1 target medication suggests to provide notable improvements in fat reduction compared to current therapies. Early research data have indicated substantial decreases in body retatrutide zphc 12